Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly - eBioMedicine
Cancer-Specific Loss of p53 Leads to a Modulation of Myeloid and T Cell Responses - ScienceDirect
Frontiers | Mutant p53 in Cancer Progression and Targeted Therapies
p53- and p16-immunostaining as surrogate marker for the different... | Download Scientific Diagram
Crosslink between p53 and metastasis: focus on epithelial–mesenchymal transition, cancer stem cell, angiogenesis, autophagy, and anoikis | SpringerLink
Class-specific features in OVCAR3 and A4 cells. A, p53 signature... | Download Scientific Diagram
p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations | Diagnostic Pathology | Full Text
The p53 pathway in breast cancer | Breast Cancer Research | Full Text
The complexity of p53 stabilization and activation | Cell Death & Differentiation
Proliferation marker Ki-67 and tumor suppressor p53 are not affected by... | Download Scientific Diagram
Oropharyngeal squamous cell carcinoma: p16/p53 immunohistochemistry as a strong predictor of HPV tumour status - Benzerdjeb - 2021 - Histopathology - Wiley Online Library
p53 may play a more important role in kidney cancer than previously thought
Frontiers | Cancer Stemness: p53 at the Wheel
Presence of p53 Protein on Spermatozoa DNA: A Novel Environmental Bio-Marker and Implications for Male Fertility | IntechOpen
IJMS | Free Full-Text | Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors
Overexpression of p53 protein is a marker of poor prognosis in Mexican women with breast cancer
p53 - Wikipedia
p53 and Tumor Suppression: It Takes a Network: Trends in Cell Biology
Conformational Altered p53 as an Early Marker of Oxidative Stress in Alzheimer's Disease | PLOS ONE
p53 positively regulates the expression of cancer stem cell marker CD133 in HCT116 colon cancer cells
P53 as a prognostic marker for bladder cancer: a meta-analysis and review - The Lancet Oncology
How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? | Cell Death & Differentiation
p53 Antibody (D07) - Bio SB
ERα determines the chemo-resistant function of mutant p53 involving the switch between lincRNA-p21 and DDB2 expressions: Molecular Therapy - Nucleic Acids
